Varicella zoster virus (strain Oka vaccine) gI&gE Protein, His Tag&Twin-Strep Tag (HPLC-verified)

Customer Reviews
Cat. No. / Size
Price
Qty
GIE-V5283-50ug
$720.00
GIE-V5283-500ug
$4120.00
ETA of in-stock products:2 business days

Product Details

  • Synonym

    Glycoprotein I & Glycoprotein E/gI & gE (VZV)

  • Source

    Varicella zoster virus (strain Oka vaccine) gI&gE Protein, His Tag&Twin-Strep Tag (GIE-V5283) is expressed from human 293 cells (HEK293). It contains AA Leu 21 - Leu 274 & Ser 31 - Ala 546 (Accession # Q77NN4 & Q9J3M8).

    Predicted N-terminus: Leu 21 & Ser 31

    Request for sequence
  • Molecular Characterization

    Glycoprotein I & Glycoprotein E/gI & gE (VZV) Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag and a twin strep tag at the C-terminus. The protein has a calculated MW of 30.1 kDa & 61.7 kDa. The protein migrates as 35-42 kDa and 60-90 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    Glycoprotein I & Glycoprotein E/gI & gE (VZV) SDS-PAGE

    Varicella zoster virus (strain Oka vaccine) gI&gE Protein, His Tag&Twin-Strep Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-HPLC

    Glycoprotein I & Glycoprotein E/gI & gE (VZV) SEC-HPLC

    The purity of Varicella zoster virus (strain Oka vaccine) gI&gE Protein, His Tag&Twin-Strep Tag (Cat. No. GIE-V5283) was greater than 85% as determined by SEC-HPLC.

  • Bioactivity-ELISA

     Glycoprotein I & Glycoprotein E/gI & gE (VZV) ELISA

    Immobilized Varicella zoster virus (strain Oka vaccine) gI&gE Protein, His Tag&Twin-Strep Tag (Cat. No. GIE-V5283) at 1 μg/mL (100 μL/well) can bind Anti-Varicella-Zoster Virus Antibody with a linear range of 0.1-1 ng/mL (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

Varicella-zoster virus (VZV) is the alphaherpesvirus that causes chicken pox (varicella) and shingles (zoster). The two VZV glycoproteins gE and gI form a heterodimer that mediates efficient cell-to-cell spread.

Recent Advances

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background